Ramesh Kumar Modukuri

Ramesh Kumar Modukuri

Active Director Director DIN 07768787
DIN 07768787 First appointment Jul 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Jul 2019
Shareholding value •••• Premium profile

About Ramesh Kumar Modukuri

Data last updated:

Ramesh Kumar Modukuri is a Director at Starus Pharmaceuticals Private Limited (since 2019), Director at Starus Pharmaceuticals Industries Private Limited (since 2019) and Director at Unicon Pharma Private Limited (since 2020). The companies operate in Pharma and Chemicals. The 3 current companies with reported revenue have a combined latest revenue of ₹32.35 Cr; the largest is Starus Pharmaceuticals Private Limited at ₹15.05 Cr (FY 2022). Earlier, Ramesh Kumar Modukuri was a Director at Sarath Meditech Private Limited (2022–2025) and Additional Director at Spectrogen Pharmachem Limited (2022).

DIN 07768787
Primary Designation Director
Industry Pharma
First Appointment 23 Jul 2019
Oldest Company Age 9 yrs
Largest company Starus Pharmaceuticals Private Limited · ₹15.05 Cr (FY 2022)
Combined revenue ₹32.35 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Jul 20192016₹15.05 Cr (FY 2022)Active
Director14 Nov 20192019₹13.72 Cr (FY 2023)Active
Unicon Pharma Private Limited U24100TG2020PTC143959
Director16 Sep 20202020₹3.58 Cr (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sarath Meditech Private Limited U24100TG2022PTC166614
Director13 Sep 20222022Active
Spectrogen Pharmachem Limited U24299TG2020PLC147109
Additional Director25 Mar 20222020₹8.21 Cr (FY 2023)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Ramesh Kumar Modukuri

Directorship timeline

Open interactive timeline →
Unicon Pharma Private Limited
Starus Pharmaceuticals Industries Private Limited
Starus Pharmaceuticals Private Limited
Sarath Meditech Private Limited
Premium access

Shareholding and investment profile for Ramesh Kumar Modukuri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramesh Kumar Modukuri

Ramesh Kumar Modukuri currently holds 3 directorships: Starus Pharmaceuticals Private Limited (Director, since 23 Jul 2019, revenue ₹15.05 Cr (FY 2022)); Starus Pharmaceuticals Industries Private Limited (Director, since 14 Nov 2019, revenue ₹13.72 Cr (FY 2023)); Unicon Pharma Private Limited (Director, since 16 Sep 2020, revenue ₹3.58 Cr (FY 2024)).

Ramesh Kumar Modukuri was first appointed on 23 Jul 2019 as Director at Starus Pharmaceuticals Private Limited. The most recent appointment on record is 13 Sep 2022 at Sarath Meditech Private Limited.

The 3 current companies of Ramesh Kumar Modukuri that report revenue have a combined latest revenue of ₹32.35 Cr: Starus Pharmaceuticals Private Limited ₹15.05 Cr (FY 2022); Starus Pharmaceuticals Industries Private Limited ₹13.72 Cr (FY 2023); Unicon Pharma Private Limited ₹3.58 Cr (FY 2024).

Ramesh Kumar Modukuri held 2 earlier board appointments: Sarath Meditech Private Limited (Director, 13 Sep 2022 to 31 May 2025); Spectrogen Pharmachem Limited (Additional Director, 25 Mar 2022 to 22 Aug 2022).

The current boards of Ramesh Kumar Modukuri's companies include Udaya Kiran Perla (Starus Pharmaceuticals Private Limited), Ravi Kumar Kollipora (Unicon Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available